about
sameAs
Hormonal contraceptives: pharmacology tailored to women's healthProteomic analysis of the reproductive organs of the hermaphroditic gastropod Lymnaea stagnalis exposed to different endocrine disrupting chemicalsComprehensive clinical management of hirsutism.Hormonal therapy in female pattern hair loss.Chlormadinone acetate (CMA) in oral contraception--a new opportunity.Is hormonal treatment still an option in acne today?A simple, rapid and sensitive liquid chromatography-tandem mass spectrometry method for the determination of dienogest in human plasma and its pharmacokinetic applications under fasting.Polycystic ovary syndrome: chemical pharmacotherapy.Recent advances in the treatment of polycystic ovary syndrome.Role of progestins with partial antiandrogenic effects.Combined oral contraceptives in the treatment of polycystic ovary syndrome.Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor.Cost-effective therapy in patients with idiopathic hirsutism.Management of severe acne.Pharmacotherapy Considerations in the Management of Transgender Patients: A Brief Review.Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.Oily Skin: A review of Treatment Options.Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.Scalp seborrheic dermatitis: prevalence and associated factors in male adolescents.Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.Oral contraceptives: their mode of action and dermatologic applications.Belara--proven benefits in daily practice.Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome.Clinical behavior of a cohort of adult women with facial acne treated with combined oral contraceptive: ethinylestradiol 20 µg/dienogest 2 mg.Testosterone levels and fecundity in the hermaphroditic aquatic snail Lymnaea stagnalis exposed to testosterone and endocrine disruptors.Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis.Increase and Redistribution of Sex Hormone Receptors in Premenopausal Women Are Associated with Varicose Vein Remodelling
P2860
Q26745814-C174FB58-C69C-4729-B269-9C06F1C15095Q28537701-B5A819D1-77AE-442D-9E7B-0A3F2BB03583Q33539381-37F84B85-B642-44F7-B649-F4933F598E58Q33641738-171CA7AE-65A1-47B2-BCF1-CB1D53EF463EQ34476856-95FD2CB2-F498-4327-8C7A-D986E40F6A32Q34667697-B7F073FB-C281-47F0-AA59-8A623BCEEA67Q35180340-12E9A828-2654-4D91-8710-5F377FF08598Q35639510-D3142DB1-6EDE-4745-ACB9-B59F68087E0BQ35906966-74440BAF-4F5F-479F-95A6-4AD781E6E060Q36019567-8D4B5830-E37F-4B41-A653-0F0986EFF966Q36080057-63B45510-0B5A-47ED-9552-E98DFF9B7901Q37084688-2B0EEC57-4776-4CA3-A953-2D0016633F49Q37609189-F150E08B-C7CD-42D8-A39B-44EC7CDD9AF3Q38322352-F726B94A-D882-4DC7-B155-602EDDF04453Q38673882-9CF26C60-24C4-4B1E-9144-D86009C08F45Q40476005-797BEA78-CA06-4453-8BDA-3AAA5BD80340Q42360928-1BE80E7B-A4ED-442D-9D34-2BC7A690281AQ42994099-4D4FC2DB-AB18-417D-B021-36042FFC5757Q44774111-EDCD3495-41DD-4093-8182-1B598C18A13EQ46145068-980694F6-C6C3-48D7-AB32-A78F8834A1CEQ46402798-DA49ABA8-0848-4082-BD14-6F5FEF28C5A3Q46852907-37D3DD4E-6123-4E7D-B704-06482F7F5B9BQ47137256-1AC56E36-01D5-4C5C-8EF2-DCEC4E4E280EQ47170985-16D44EA8-701B-4B55-856F-1399F8C301C8Q51533364-38838C33-19F4-4543-A0A4-559F98F0B46FQ55256140-3C6FF009-8C64-4211-96D1-74C2E83A4642Q58766945-429E6F19-05F6-4CBF-8E91-966C1F3A4088
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Progestogens with antiandrogenic properties
@ast
Progestogens with antiandrogenic properties
@en
Progestogens with antiandrogenic properties
@nl
type
label
Progestogens with antiandrogenic properties
@ast
Progestogens with antiandrogenic properties
@en
Progestogens with antiandrogenic properties
@nl
prefLabel
Progestogens with antiandrogenic properties
@ast
Progestogens with antiandrogenic properties
@en
Progestogens with antiandrogenic properties
@nl
P1433
P1476
Progestogens with antiandrogenic properties
@en
P2093
Daniel Raudrant
Thomas Rabe
P304
P356
10.2165/00003495-200363050-00003
P407
P577
2003-01-01T00:00:00Z
P6179
1032908380